Literature DB >> 21195374

Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis.

Erica Villa1, Giovanna Fattovich, Antonella Mauro, Michela Pasino.   

Abstract

The evaluation of the natural history of chronic hepatitis B virus (HBV) infection requires the precise definition of the various clinical conditions that can be encountered (i.e. inactive carrier state or subject with liver disease activity). This can be achieved by repeat monitoring of ALT, serum HBV-DNA levels (over a period of at least 1 year, according to international guidelines) and/or evaluation of HBsAg titre. Liver biopsy may offer additional information although it is not mandatory. Overall, the natural history of the true inactive carrier is benign: reactivation of hepatitis, especially in Western countries, is rare and is usually due to co-factors (like alcohol or drugs); spontaneous HBsAg loss is frequent (around 1% per year) and HCC development rare. On the other hand, in patients with chronic hepatitis B or cirrhosis, the risk of reactivation, of HCC development and of liver-related mortality is much higher, especially in Eastern countries, and should therefore lead to antiviral therapy. Copyright Â
© 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21195374     DOI: 10.1016/S1590-8658(10)60686-X

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  23 in total

1.  Viral factors and outcome of chronic hepatitis B revisited.

Authors:  François Habersetzer; Rémy Moenne-Loccoz; Thomas F Baumert
Journal:  Hepatol Int       Date:  2013-09-11       Impact factor: 6.047

2.  Epidemiology of hepatitis D virus (HDV) infection in an urban area of northern Italy.

Authors:  M De Paschale; M T Manco; L Belvisi; C Magnani; T Re; P Viganò; S Biagiotti; F Capelli; A Mazzone; M P Baldacci; A Ferrara; A L Neri; C M Guastoni; R A Bonazzina; B Brando; P Clerici
Journal:  Infection       Date:  2012-02-25       Impact factor: 3.553

Review 3.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

4.  Serum ferritin and the risk of hepatocellular carcinoma in chronic liver disease of viral etiology: a case-control study.

Authors:  Prachi S Patil; K M Mohandas; Shobna J Bhatia; Shaesta A Mehta
Journal:  Indian J Gastroenterol       Date:  2013-09-05

5.  Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.

Authors:  Li Wang; Zhi-Qiang Zou; Kai Wang; Ji-Guang Yu; Xiang-Zhong Liu
Journal:  Hepatol Int       Date:  2015-10-01       Impact factor: 6.047

6.  The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.

Authors:  Takashi Taida; Makoto Arai; Tatsuo Kanda; Shuhei Hige; Yoshiyuki Ueno; Fumio Imazeki; Namiki Izumi; Eiji Tanaka; Noboru Shinkai; Kentaro Yoshioka; Yasunari Nakamoto; Shuhei Nishiguchi; Masataka Tsuge; Masanori Abe; Michio Sata; Hiroshi Yatsuhashi; Akio Ido; Kazuhiko Kita; Ryousaku Azemoto; Yoshio Kitsukawa; Nobuaki Goto; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2016-06-15       Impact factor: 7.527

7.  Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

Authors:  Amelia Jazwa; Margaret S Coleman; Julie Gazmararian; La'Marcus T Wingate; Brian Maskery; Tarissa Mitchell; Michelle Weinberg
Journal:  Vaccine       Date:  2015-01-14       Impact factor: 3.641

8.  HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients.

Authors:  Meta Dewi Thedja; Susan Irawati Ie; Alida Roswita Harahap; Korri Elvanita El-Khobar; Martono Roni; David Handojo Muljono
Journal:  Hepatol Int       Date:  2013-05-23       Impact factor: 6.047

Review 9.  Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections.

Authors:  Xuefen Li; Xia Liu; Li Tian; Yu Chen
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

10.  Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia.

Authors:  Kali Zhou; Abdus S Wahed; Stewart Cooper; Adrian M Di Bisceglie; Robert J Fontana; Marc G Ghany; Mandana Khalili; Anna S Lok; Robert Perrillo; William M Lee; Daryl T Y Lau; Richard Sterling; Harry L A Janssen; Norah A Terrault
Journal:  Am J Gastroenterol       Date:  2019-11       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.